NCT04160169

Brief Summary

The main objective of the evaluation was to assess the effect of providing injectable and HIV risk counseling messages on contraceptive knowledge and behavior during a three month pilot intervention in ten healthcare facilities in Tanzania.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Sep 2018

Shorter than P25 for all trials

Geographic Reach
1 country

10 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2018

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2018

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

November 7, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 12, 2019

Completed
Last Updated

November 12, 2019

Status Verified

November 1, 2019

Enrollment Period

3 months

First QC Date

November 7, 2019

Last Update Submit

November 8, 2019

Conditions

Keywords

CounselingTanzania

Outcome Measures

Primary Outcomes (3)

  • Number of clients obtaining an injectable during their family planning appointment

    Injectable uptake of interviewed clients

    After implementation of counseling messages, up to 13 weeks

  • Percent of clients obtaining an injectable during their family planning appointment

    Injectable uptake of interviewed clients

    After implementation of counseling messages, up to 13 weeks

  • Monthly total number of family planning clients by method obtained

    Contraceptive uptake during pilot intervention

    September 2017 through November 2018

Secondary Outcomes (6)

  • Number of correct hormonal contraception and HIV risk counseling messages mentioned during spontaneous recall

    After implementation of counseling messages, up to 13 weeks

  • Percent of correct hormonal contraception and HIV risk counseling messages mentioned during spontaneous recall

    After implementation of counseling messages, up to 13 weeks

  • Number of correct True/False statements on hormonal contraception and HIV (11 total)

    After implementation of counseling messages, up to 13 weeks

  • Percent of correct True/False statements on hormonal contraception and HIV (11 total)

    After implementation of counseling messages, up to 13 weeks

  • Number of interviewed clients reporting an intention to use condoms as a dual method

    After implementation of counseling messages, up to 13 weeks

  • +1 more secondary outcomes

Interventions

Counseling messages based on 2017 World Health Organization guidance, a review of the Strategic Communication Framework for Hormonal Contraceptive Methods and Potential HIV-related Risks, and the Family Planning Global Handbook were provided to clients expressing interest in injectables during regular family planning appointments.

Eligibility Criteria

Age15 Years - 49 Years
Sexfemale
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

All women attending a participating healthcare facility during the three month intervention period and who met eligibility criteria received the hormonal contraception and HIV risk messages.

You may qualify if:

  • Expressed interest in injectable use
  • HIV-negative or unknown HIV status

You may not qualify if:

  • Positive HIV status known to healthcare provider

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (10)

Ilula Hospital

Ilula, Iringa, Tanzania

Location

Mafinga Hospital

Mafinga, Iringa, Tanzania

Location

Ihongole Health Center

Iringa, Tanzania

Location

Ipogolo Health Center

Iringa, Tanzania

Location

Kimande Health Center

Iringa, Tanzania

Location

Ipelele Health Center

Njombe, Tanzania

Location

Kibena Regional Referral Hospital

Njombe, Tanzania

Location

Makambako Hospital

Njombe, Tanzania

Location

Makete Hospital

Njombe, Tanzania

Location

Njombe Health Center

Njombe, Tanzania

Location

Related Links

Study Officials

  • Janine Barden-O'Fallon, PhD

    University of North Carolina, Chapel Hill

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 7, 2019

First Posted

November 12, 2019

Study Start

September 1, 2018

Primary Completion

November 30, 2018

Study Completion

November 30, 2018

Last Updated

November 12, 2019

Record last verified: 2019-11

Data Sharing

IPD Sharing
Will share

Deidentified data from the client interviews are publicly available through MEASURE Evaluation Dataverse in STATA format. The study report is also available on Dataverse.

Shared Documents
CSR
Time Frame
Data are currently available and will remain on Dataverse.org
Access Criteria
Site registration required.
More information

Available IPD Datasets

Individual Participant Data Set (doi:10.15139/S3/XEXQXO)Access

Locations